The field of obesity management is seeing a lot of research and product development activities.This research service provides a detailed analysis of the technology developments and industry dynamics for obesity drugs. An evaluation of the adoption of obesity drugs has been discussed (regionwise) and some of the emerging areas of obesity research has also been highlighted. Some of the key industry drivers and challenges along with their market impact have been discussed.

Table Of Contents

Table of Contents


Executive Summary
Research Scope and Methodology 1
Research Scope and Segmentation1
Research Methodology 2
Research Overview 3
Introduction to Obesity and Anti-Obesity Drugs3
Key Findings and Analyst Insights 4
Technology Snapshot and Impact Analysis
Technology Snapshot 6
Anti-Obesity Drugs Classified on the Mode of Action6
Value Chain for Anti-Obesity Drugs 12
Assessment of Factors Influencing Adoption of Anti-Obesity Drugs 15
Market Impact of Key Drivers 15
Impact of Key Challenges and Restraints17
Regulatory Scenario 20
Diffusion of Innovations and Opportunity Evaluation
Diffusion of Innovation 23
Adoption of Anti-Obesity Drugs--North America 23
Adoption of Anti-Obesity Drugs--Europe and Asia Pacific 25
Overview of Partnerships and Alliances in the Industry 27
Opportunity Evaluation 31
Opportunity Strategy Evaluation of Anti-Obesity Drugs 31
Roadmap--Emerging Areas to Focus 34
Key Patents and Contacts
Key Patents 37
Issued Patents 37
Applied Patents40
Contacts 43
Corporate Contacts43
Academic Contacts44
D2A1 © 2011 Frost and Sullivan www frost com v
Pharmaceutical Management of Obesity
vi D2A1 © 2011 Frost and Sullivan www frost com
Decision Support Database
Decision Support Database Tables 46
Prevalence of Obese Population (2004-2014) 46
Pharmaceutical RandD Expenditure (2002-2012) 48
Total Healthcare Expenditure (2004-2014)50

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The prostate cancer pipeline is among the largest in the ...

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • October 2014
  • by GBI Research

Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in NSCLC Pipeline The NSCLC pipeline currently has 389 products in active development ...

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • November 2014
  • by GBI Research

Frontier Pharma: Parkinson's Disease - Identifying and Commercializing First-in-Class Innovation Summary Large Degree of Innovation in Parkinson's Disease Pipeline The Parkinson's disease (PD) pipeline ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.